Literature DB >> 6652570

Cicatricial ectropion due to essential skin shrinkage: treatment with rotational upper-lid pedicle flaps.

J J Hurwitz, M Lichter, J Rodgers.   

Abstract

Ectropion is sometimes due to a shortage of skin of the lower lid (cicatricial) and may result from previous surgery, trauma, burns, skin diseases etc. Excessive exposure to the sun has also been incriminated. Vertical traction lines in the skin of the lower lid, accentuated by gazing up or by opening the mouth, suggest this condition. This paper describes the use of pedicle skin flaps rotated from the upper lid to treat cicatricial ectropion occurring in the absence of any predisposing factor and not responding to conservative treatment--that is, due to essential skin shrinkage. All 10 patients had an improved appearance, and epiphora persisted in only 1 patient, who subsequently underwent a punctum-enlarging procedure. In an 11th patient there was insufficient redundant upper-lid skin, so a free skin graft was used instead.

Entities:  

Mesh:

Year:  1983        PMID: 6652570

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  4 in total

1.  The tight retracted lower eyelid.

Authors:  R G Small; M Scott
Journal:  Trans Am Ophthalmol Soc       Date:  1989

2.  Anterior lamellar deficit ectropion management.

Authors:  Kaveh Vahdani; Vladimir Theodor Thaller
Journal:  Eye (Lond)       Date:  2020-06-03       Impact factor: 3.775

3.  A lateral tarsorrhaphy with forehead hitch to pre-empt and treat burns ectropion with a contextual review of burns ectropion management.

Authors:  Nikolaos S Lymperopoulos; Daniel J Jordan; Ranjeet Jeevan; Kayvan Shokrollahi
Journal:  Scars Burn Heal       Date:  2016-04-22

4.  Vertical-to-Horizontal Rotational Myocutaneous Flap for Repairing Cicatricial Lower Lid Ectropion: A Novel Surgical Technique.

Authors:  Yu-Fan Chang; Chieh-Chih Tsai; Hui-Chuan Kau; Catherine Jui-Ling Liu
Journal:  Biomed Res Int       Date:  2017-10-18       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.